ERBB2 and cancer: We chose the following two model systems for invasion studies because (a) they are resistant to 2nd line HER2 inhibitor treatment, (b) they have retained the typical aggressive invasiveness of HER2 positive cancer and (c) they can grow as 3-dimensional structures, thus better representing actual tumor growth than can be achieved with 2-dimensional cultures.